Diagnosis and management of radiation cholecystitis as a complication of Y90 radioembolization for hepatocellular carcinoma

Radiation induced cholecystitis is a known but rare complication of Yttrium90 (Y90) radioembolization of hepatic tumors due to nontarget embolization. Many documented cases of radiation induced cholecystitis have been treated with cholecystectomy, which is significant given the typical patient popul...

Full description

Bibliographic Details
Published in:	Radiology Case Reports
Main Authors:	Joe Khoury, DO, MBA, Brenden Li, BS, Joyce Zhu, BS, Trevor Lin, BS, Eusha Hasan, BA, Ashley Lamba, BS, Vaiva Gustainyte, DO, Hakob Kocharyan, MD, Christopher Yeisley, MD, Elias Salloum, MD, Altan Ahmed, MD, Craig Greben, MD, Mustafa Al-Roubaie, MD
Format:	Article
Language:	English
Published:	Elsevier 2024-08-01
Subjects:	Radioembolization Y90 Radiation cholecystitis Hepatocellular carcinoma Interventional oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1930043324003972

Similar Items

Cholecystitis after yttrium-90 resin microsphere radioembolization treatment: Clinical and pathologic findings
by: Sagun Parakh, et al.
Published: (2016-07-01)

Yttrium-90 Radioembolization for Hepatic Metastases Secondary to Thymic Malignancies: A Case Report
by: Gavin Yuan, BA, et al.
Published: (2025-05-01)

Radioembolization and the dynamic role of 90Y PET/CT
by: Alexander S Pasciak, et al.
Published: (2014-02-01)

Radioembolization for hepatocellular carcinoma: what clinicians need to know
by: Jin Woo Choi, et al.
Published: (2022-03-01)

A Comparison of Techniques for 90Y PET/CT Image-Based Dosimetry following Radioembolization with Resin Microspheres
by: Alexander Samuel Pasciak, et al.
Published: (2014-05-01)

Trans-arterial 90yttrium radioembolization for patients with unresectable tumors originating from the biliary tree
by: Joost W. Wijlemans, et al.
Published: (2011-07-01)

Radioembolization Treatment for Liver Cancer
by: Ezgi Başak ERDOĞAN, et al.
Published: (2016-04-01)

Liver Radioembolization: a New Chapter in Russian Oncology
by: A. D. Kaprin, et al.
Published: (2019-12-01)

A Clinical Trial of The Evaluation of Environmental Exposure in Yttrium 90 Radioembolization
by: Handan Tanyildizi, et al.
Published: (2018-12-01)

Predictors of Hepatic Decompensation after Yttrium90 Transarterial Radioembolization—Optimizing Patient Selection
by: Amelia Wong, et al.
Published: (2024-08-01)

Single-Compartment Dose Prescriptions for Ablative <sup>90</sup>Y-Radioembolization Segmentectomy
by: Srinivas Cheenu Kappadath, et al.
Published: (2023-05-01)

Yttrium-90 radioembolization in patients with hepatocellular carcinoma who have previously received sorafenib
by: Nitesh eRana, et al.
Published: (2013-12-01)

Ipilimumab and nivolumab plus radioembolization as salvage therapy for atezolizumab and bevacizumab refractory hepatocellular carcinoma resulting in complete pathologic response
by: Claudia R. Silver, BS, et al.
Published: (2024-11-01)

Single-system outcomes after adopting yttrium-90 radioembolization with personalized dosimetry as the primary treatment approach for unresectable, solitary hepatocellular carcinoma
by: A. Zamani, et al.
Published: (2026-03-01)

Yttrium-90 Radioembolization as the Major Treatment of Hepatocellular Carcinoma
by: Yu CY, et al.
Published: (2023-01-01)

Precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model
by: E. Courtney Henry, et al.
Published: (2022-03-01)

Yttrium-90 Radioembolization of Metastatic Adrenocortical Carcinoma to the Liver following Systemic Chemotherapy and Surgical Resection of the Primary Lesion
by: Nicholas Pigg, et al.
Published: (2020-02-01)

Outcomes of Y90 Radioembolization for Hepatocellular Carcinoma in Patients Previously Treated with Transarterial Embolization
by: Ken Zhao, et al.
Published: (2024-05-01)

Optimization of 99mTc-SPECT in the presence of 90Y for radioembolization
by: Camiel E.M. Kerckhaert, et al.
Published: (2025-09-01)

Software development for hepatopulmonary shunt estimation by gamma camera method in transarterial radioembolization
by: Ashish Jha Jha, et al.
Published: (2019-10-01)

Combination of transarterial radioembolization with atezolizumab and bevacizumab for intermediate and advanced staged hepatocellular carcinoma: A preliminary report of safety and feasibility
by: Qian Yu, et al.
Published: (2023-11-01)

Radioembolization: Emerging Opportunities in the Era of Personalized Medicine
by: Cicero Matthew R Habito
Published: (2015-10-01)

90Y SPECT scatter estimation and voxel dosimetry in radioembolization using a unified deep learning framework
by: Yixuan Jia, et al.
Published: (2023-12-01)

Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases
by: Nicholas Fidelman, et al.
Published: (2022-12-01)

Efficacy and safety of Y90 radioembolization combined with targeted therapy and immunotherapy in patients with unresectable hepatocellular carcinoma: a dual-center, retrospective study
by: Xiaolong Wang, et al.
Published: (2026-04-01)

The Influence of Additional Treatments on the Survival of Patients Undergoing Transarterial Radioembolization (TARE)
by: Natale Quartuccio, et al.
Published: (2024-03-01)

Short-term changes of angiogenesis factors after transarterial radioembolization in hepatocellular carcinoma patients
by: Hüseyin Tuğsan Ballı, et al.
Published: (2023-09-01)

The Essential Role of Monte Carlo Simulations for Lung Dosimetry in Liver Radioembolization with <sup>90</sup>Y Microspheres
by: Edoardo d’Andrea, et al.
Published: (2024-08-01)

A systematic review on the safety and effectiveness of yttrium-90 radioembolization for hepatocellular carcinoma with portal vein tumor thrombosis
by: Zhongzhi Jia, et al.
Published: (2016-01-01)

Ablative radioembolization of hepatocellular carcinoma with total arterial supply originating from the superior adrenal artery achieved complete pathologic necrosis
by: Gonzalo Arotzarena, BS, et al.
Published: (2023-01-01)

Identifying key predictors of mortality and liver decompensation in hepatocellular carcinoma patients treated with transarterial radioembolization
by: Mohammad Arabi, et al.
Published: (2025-05-01)

Real-life experience in the treatment of gallbladder carcinoma by transarterial radioembolization: a multicenter retrospective study
by: Thomas Dertnig, et al.
Published: (2026-05-01)

Transarterial radioembolization versus chemoembolization for hepatocellular carcinoma: a meta-analysis
by: Wenxiao Lu, et al.
Published: (2025-01-01)

Chemorefractory liver metastasis from cervical cancer successfully treated with a combination of yttrium-90 and immunotherapy
by: Michael E. Nance, et al.
Published: (2020-08-01)

Rapid predictive dosimetry for radioembolization
by: Yung Hsiang Kao
Published: (2024-01-01)

Optimization of Y-90 Radioembolization Imaging for Post-Treatment Dosimetry on a Long Axial Field-of-View PET/CT Scanner
by: Pia M. Linder, et al.
Published: (2023-11-01)

Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres
by: Hoda Roshan, et al.
Published: (2015-04-01)

Safety and Efficacy of Concurrent Atezolizumab/Bevacizumab or Nivolumab Combination Therapy with Yttrium-90 Radioembolization of Advanced Unresectable Hepatocellular Carcinoma
by: Alexander Villalobos, et al.
Published: (2023-11-01)

Yttrium-90 Radioembolization Versus Transarterial Embolization for Lung Carcinoid Hepatic Metastasis
by: Gavin Yuan, MD, et al.
Published: (2026-05-01)

Voxel-S-value methods adapted to heterogeneous media for quantitative Y-90 microsphere radioembolization dosimetry
by: Gefei Chen, et al.
Published: (2023-02-01)